Case-in-a-Box | Shockwave

Monday, March 9, 2026

3:15 PM - 3:45 PM EST

Location: Jefferson

Moderator(s)

Robert M. Bersin, MD, MPH, FSCAI

Medical Director, Endovascular Services
Swedish Heart and Vascular (Emeritus)
Parc de la Baie Orientale, France

Disclosure(s): Nectero, Inc.: Stock-privately held company (Ongoing)
Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure information not submitted.
Rachel Rosovsky, MD, MPH

Associate Professor, Harvard Medical school
Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.

Panel Discussant(s)

Mohammad M. Ansari, MD

Assistant Professor/ Cath Lab Director
Texas Tech University Health Sciences Center
Lubbock, Texas, United States

Disclosure information not submitted.
Subhash Banerjee, MD

Chief of Cardiovascular Research & Innovation
Baylor Scott & White Heart and Vascular Institute, Dallas, TX
Dallas, Texas, United States

Disclosure(s): AngioSafe: Consulting Fees (e.g., advisory boards) (Ongoing); Esperion: Grant/Research Support (Ongoing); GE Healthcare Bio-Sciences: Grant/Research Support (Ongoing); Kaneka: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Grant/Research Support (Ongoing); Phillips: Grant/Research Support (Ongoing); Teleflex: Grant/Research Support (Ongoing)
Riyaz Bashir, MD

Director Vascular and Endovascular Medicine
Mayo Clinic Florida
Jacksonville, Florida, United States

Disclosure(s): Thrombolex: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing)
Robert E. Beasley, MD, FSIR, FSCAI

Director of Research and Endovascular Specialist
Palm Vascular Centers of MB and Coral Gables
Miami, Florida, United States

Disclosure(s): No financial relationships to disclose
Khusrow A. Niazi, MD, FACC, FSCAI, FSVM

Director Peripheral Vascular Interventions
Emory University
Dunwoody, Georgia, United States

Disclosure(s): Cordis, Endovascular Division: Grant/Research Support (Ongoing)
Gregory Piazza, MD

Staff Physician
Brigham and Women's Hospital
Boston, Massachusetts, United States

Disclosure(s): BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Esperion, Regeneron, NIH 1R01HL164717-01: Grant/Research Support (Ongoing); BSC, Amgen, Thrombolex, Penumbra, BMS/Pfizer, NAMSA, BMS, Janssen: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Robert M. Bersin, MD, MPH, FSCAI: Nectero, Inc.: Stock-privately held company (Ongoing)

Subhash Banerjee, MD: AngioSafe: Consulting Fees (e.g., advisory boards) (Ongoing); Esperion: Grant/Research Support (Ongoing); GE Healthcare Bio-Sciences: Grant/Research Support (Ongoing); Kaneka: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Grant/Research Support (Ongoing); Phillips: Grant/Research Support (Ongoing); Teleflex: Grant/Research Support (Ongoing)

Riyaz Bashir, MD: Thrombolex: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing)

Robert E. Beasley, MD, FSIR, FSCAI: No financial relationships to disclose

S. Jay Mathews, MD: Abiomed: Grant/Research Support (Ongoing); Akura: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gore: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Innova vascular: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Stock Options [in privately held companies] (Ongoing); R3: Grant/Research Support (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Options [in privately held companies] (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Khusrow A. Niazi, MD, FACC, FSCAI, FSVM: Cordis, Endovascular Division: Grant/Research Support (Ongoing)

Gregory Piazza, MD: BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Esperion, Regeneron, NIH 1R01HL164717-01: Grant/Research Support (Ongoing); BSC, Amgen, Thrombolex, Penumbra, BMS/Pfizer, NAMSA, BMS, Janssen: Consulting Fees (e.g., advisory boards) (Ongoing)